Research into cardiac autonomic control has received great interest in the past 20 years,
and we are now at a critical juncture with regard to the clinical translation of the experimental …

Increasing maternal mortality and incidence of arrhythmias in pregnancy have been noted
over the past 2 decades in the United States. Pregnancy is associated with a greater risk of …

Background: Cardiac sympathetic denervation (CSD) has been shown to reduce the burden
of implantable cardioverter-defibrillator (ICD) shocks in small series of patients with …

Objectives: The study sought to characterize the efficacy of stellate ganglion block (SGB) as
a treatment for electrical storm (ES). Background: The efficacy of percutaneous SGB for …

Ventricular arrhythmias (VA) can range in presentation from asymptomatic to cardiac arrest
and sudden cardiac death (SCD). Sustained ventricular tachycardias/ventricular fibrillation …

Cardiac sympathetic denervation (CSD) is reported to reduce the burden of ventricular
tachyarrhythmias [ventricular tachycardia (VT)/ventricular fibrillation (VF)] in cardiomyopathy …

Myocardial infarction causes sympathetic activation and parasympathetic dysfunction, which
increase risk of sudden death due to ventricular arrhythmias. Mechanisms underlying …

Heart failure (HF) is a major public health problem worldwide, especially coronary heart
disease (myocardial infarction)-induced HF with reduced ejection fraction (HFrEF), which …

An ageing myocardium possesses significant electrophysiological alterations that
predisposes the elderly patient to arrhythmic risk. Whilst these alterations are intrinsic to the …

The short-chain fatty acid (SCFA) propionate (C3), a microorganism metabolite produced by
gut microbial fermentation, has parasympathetic-activation effects. The cardiac autonomic …